semaglutide

Sun Pharma announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a…

Lupin announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings SA (LAHSA) with Galenicum Health,…

With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…

Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular…

The warnings were issued on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic…

Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes

The constrained supply of Wegovy and the necessity of ongoing obesity management support are key considerations

Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…

Triple combination regimen to be investigated in new Phase 2b study in NASH patients with cirrhosis

The drug, semaglutide, works by hijacking the body's own appetite-regulating system in the brain leading to reduced hunger and…